Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|21|2609-2622

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.21, 2006-07, pp. : 2609-2622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 1000-1017

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 731-745

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 2, 2007-04 ,pp. : 151-160

Bentham Science Publishers

Access to resources Recommend Favorite

Investigation of vascular endothelial growth factor effects on pulmonary endothelial monolayer permeability and neutrophil transmigration

By Cullen V.C.   Mackarel A.J.   Hislip S.J.   O'Connor C.M.   Keenan A.K.  

General Pharmacology, Vol. 35, Iss. 3, 2000-09 ,pp. : 149-157

Elsevier

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite